Doxazosin Tablet
Product Images NDC 0904-5523

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 0904-5523). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxazosin-structure (Doxazosin Structure)

Chemical structure diagram of Doxazosin mesylate, showing the molecular arrangement of the active ingredient Doxazosin with a mesylate group.*

FDA Label Image

Figure1.jpg (Figure1)

Two line graphs comparing Doxazosin and placebo over 14 weeks of treatment. The left graph shows mean change in total symptom score from baseline, with Doxazosin showing greater symptom reduction than placebo. The right graph depicts mean increase in maximum urinary flow rate from baseline, with Doxazosin showing a higher increase compared to placebo. Both graphs note statistical significance with markers.*

FDA Label Image

Bottle Label (Image 01)

Doxazosin tablets, USP 1 mg oral tablets by Major Pharmaceuticals, Unit Dose packaging containing 100 tablets. Label includes directions for pharmacist to dispense with patient information leaflet. NDC 0904-5522-61 is shown, along with manufacturer and distributor information.*

FDA Label Image

Bottle Label (Image 02)

Label for Doxazosin Tablets USP 2 mg by Major Pharmaceuticals. It includes the NDC number 0904-5523-61 and specifies unit dose packaging with 100 tablets. The label notes prescription use only, pharmacist dispensing instructions with a patient information leaflet, and storage conditions between 20° to 25°C. Manufacturer and distributor addresses are also provided.*

FDA Label Image

Bottle Label (Image 03)

Doxazosin tablets, USP 4 mg, unit dose packaging from Major Pharmaceuticals. The label includes dosing strength, prescription-only (Rx only) status, dispensing instructions to provide patient information leaflets, quantity of 100 tablets, and storage conditions. Manufacturer, packager, and distributor information is also printed along with barcode and NDC number 0904-5524-61.*

FDA Label Image

Table3.jpg (Table3)

Data table summarizing symptom score and maximum flow rate changes from placebo-controlled trials of Doxazosin. It includes three studies with various dosages, showing mean baseline and mean change values for symptom scores and flow rates, alongside a bar graph illustrating maximum flow rate improvements in Study 2. Statistical significance indicators are noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.